Skip to main content
. 2018 Apr 1;2018:1543034. doi: 10.1155/2018/1543034

Table 4.

Network meta-analysis results of mean change in prolactin from baseline by patient sex.

Females only
Males only Placebo 45.39
(26.02, 64.96)
83.93
(51.04, 117.00)
21.06
(7.11, 34.99)
19.41
(0.83, 37.88)
−1.47 
(−22.03, 19.02)
17.83 
(−1.72, 37.39)
20.09 
(−2.59, 43.13)
19.07
(7.38, 30.93)
Risperidone
1–3 mg/day
38.41
(3.66, 73.84)
24.38
(48.30, 0.35)
−26.03 
(−52.87, 1.00)
46.86
(75.20, 18.82)
27.58
(55.01, 0.15)
−25.30 
(−55.39, 4.43)
29.46
(17.20, 41.73)
10.36 
(−2.01, 22.94)
Risperidone
4–6 mg/day
62.85
(98.96, 27.00)
64.48
(102.70, 26.72)
85.25
(124.90, 46.32)
66.09
(104.50, 27.90)
63.70
(103.40, 24.08)
−2.70 
(−8.97, 3.59)
21.83
(35.26, 8.46)
32.17
(46.08, 18.40)
Quetiapine
400 mg/day
−1.69 
(−17.11, 13.71)
−22.52 
(−47.18, 2.14)
−3.20 
(−27.30, 20.91)
−0.90 
(−27.88, 25.88)
2.81 
(−2.95, 8.54)
16.27
(29.36, 3.18)
26.65
(40.29, 13.13)
5.54 
(−0.04, 11.05)
Quetiapine
800 mg/day
−20.80 
(−48.43, 6.66)
−1.48 
(−28.68, 25.29)
0.67 
(−28.60, 29.87)
3.04 
(−4.82, 10.87)
16.05
(30.30, 2.08)
26.43
(41.22, 11.94)
5.71 
(−4.30, 15.74)
0.23 
(−9.52, 9.86)
Paliperidone
1.5 mg/day
19.32 
(−7.47, 45.84)
21.50 
(−7.73, 50.80)
22.18
(10.88, 33.43)
3.04 
(−13.14, 19.30)
−7.33 
(−23.97, 9.28)
24.87
(11.96, 37.86)
19.35
(6.66, 31.87)
19.16
(6.50, 31.75)
Paliperidone
3–6 mg/day
2.32 
(−25.95, 31.03)
20.61
(9.40, 32.00)
1.54 
(−14.70, 17.62)
−8.87 
(−25.30, 7.58)
23.35
(10.46, 36.24)
17.82
(5.19, 30.41)
17.59
(4.98, 30.30)
−1.52 
(−16.40, 13.56)
Paliperidone
6–12 mg/day

The results of the fixed effects NMA are displayed. Data are presented as mean difference (95% credible interval). Values correspond to the mean differences in the column versus the row for the upper triangle and the mean differences in the row versus the column for the lower triangle. Values in bold are those differences that are statistically important.